Semaglutide
Peptide Therapy in Pasadena

What Is Semaglutide?

Semaglutide is a GLP-1 receptor agonist used alongside nutrition, physical activity and ongoing medical care. Depending on the approved indication, individual medical needs and applicable prescribing requirements, semaglutide may be available as an oral tablet, an injectable medication or a compounded preparation.

Available treatment formats

Oral, Injectable and Compounded Options

FDA-approved Ozempic® and Wegovy® products are available in oral and injectable formulations. Each product has specific approved indications, dosing instructions and prescribing requirements.

When a patient has a medical need that cannot be met by an FDA-approved product, a clinician may consider a compounded preparation when clinically appropriate, legally permitted and available through a properly licensed pharmacy.

The appropriate option depends on the patient’s medical history, treatment goals, evaluation, medication availability and applicable prescribing information.

Ozempic® Oral Ozempic® Injectable Wegovy® Oral Wegovy® Injectable Compounded Options
Before treatment

What We Evaluate

  • Medical and medication history
  • Metabolic health and laboratory results
  • Lifestyle and nutrition
  • Body composition
  • Individual risks and long-term goals
Personalized selection

Choosing a Formulation

  • Approved indication and treatment goals
  • Oral or injectable preference
  • Medical history and current medications
  • Availability and prescribing requirements
  • Need for ongoing monitoring and follow-up

Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality before they are marketed. They may be considered only when a patient’s medical needs cannot be met by an available FDA-approved medication. Eligibility and availability are determined through medical evaluation and applicable federal and state requirements.

Meet with our medical team to discuss which available formulation may be appropriate for your health needs and treatment goals.

Book Your Consultation

Potential Benefits of Semaglutide

Depending on the approved product, individual health needs, and treatment plan, semaglutide may support several metabolic and weight-management goals.

Weight management

Clinically Meaningful Weight Reduction

Semaglutide may support gradual weight reduction when combined with nutrition, physical activity, and ongoing medical care.

Glucose regulation

Improved Blood Sugar Control

In appropriate patients, semaglutide can improve glycemic control and reduce HbA1c.

  • Fasting glucose
  • HbA1c
  • Post-meal glucose regulation
Appetite support

Reduced Appetite and Cravings

Slower gastric emptying and GLP-1 signaling may improve fullness, reduce appetite, and support smaller portions.

Cardiometabolic health

Risk Reduction in Eligible Patients

Certain FDA-approved semaglutide products carry cardiovascular or kidney-related risk-reduction indications for qualifying patients.

Whole-person care

Body-Composition Support

Nutrition, resistance training, and clinical monitoring help support metabolic health and lean-mass preservation—not just changes on the scale.

Individual results vary. Benefits and risks depend on the prescribed product, medical history, dose, treatment adherence, and lifestyle factors. Semaglutide does not replace nutrition, physical activity, or ongoing medical care.

How Semaglutide Treatment Works

At Alpha Hormones®, treatment follows an individualized, physician-guided process focused on safety, metabolic health, and sustainable progress.

Comprehensive Evaluation

  • Medical and medication history
  • Weight and metabolic assessment
  • Nutrition and lifestyle review
  • Hormone and body-composition evaluation
  • Personal treatment goals

Your provider looks beyond scale weight to understand the broader metabolic and hormonal picture.

Lab and Metabolic Testing

  • Fasting glucose and HbA1c
  • Insulin and metabolic markers
  • Lipid panel
  • Kidney and liver function
  • Thyroid and hormone testing when appropriate

Testing helps identify metabolic concerns and establish a baseline for ongoing monitoring.

Eligibility and Risk Screening

  • Personal or family history of medullary thyroid carcinoma
  • Multiple Endocrine Neoplasia syndrome type 2
  • Pancreatitis and gallbladder history
  • Severe gastrointestinal conditions
  • Pregnancy plans and medication interactions

A licensed provider determines whether semaglutide is appropriate and which product fits the clinical need.

Gradual Dose Titration

Treatment generally begins at a low dose and increases gradually according to the prescribed product, clinical response, and tolerability.

  • Individualized dosing schedule
  • Administration guidance
  • Side-effect prevention and education
  • Adjustments based on response

Doses should never be increased faster than directed by the prescribing provider.

Monitoring and Optimization

  • Weight and body-composition tracking
  • Blood glucose and laboratory reassessment
  • Appetite and nutrition review
  • Symptoms and side-effect monitoring
  • Dose adjustments when clinically appropriate

The goal is sustainable progress—not rapid or aggressive dose escalation.

Integrated Metabolic Care

  • Nutrition and physical-activity planning
  • Resistance training and muscle preservation
  • Hormone and thyroid management
  • Sleep and recovery support
  • Long-term weight-maintenance planning

Semaglutide works best as one component of a comprehensive metabolic-health strategy.

Individualized prescribing matters. Available semaglutide products differ in formulation, approved indication, dosing, and administration. Treatment should be started, adjusted, or discontinued only under the guidance of a licensed provider.

Medication and Pharmacy Options

Medication selection depends on the approved indication, medical history, insurance coverage, availability, and individual clinical needs.

Preferred when appropriate

FDA-Approved Semaglutide

FDA-approved products have been evaluated for quality, safety, effectiveness, dosing, and manufacturing consistency.

  • Prescribed for the product’s approved indication
  • Standardized formulation and dosing
  • Dispensed through licensed U.S. pharmacies
  • Product-specific instructions and safety information
Ozempic® Wegovy® Rybelsus®
Limited circumstances

Patient-Specific Compounding

Compounded semaglutide is not FDA-approved. It may be considered only when legally permissible and when a prescriber documents a patient-specific need that an available approved product cannot meet.

  • Requires an individualized prescription
  • Must come from an appropriately licensed pharmacy
  • Requires careful dose and administration education
  • Should use the appropriate semaglutide base ingredient
  • Requires clinical monitoring and follow-up

Our Medication Standards

Clinical appropriateness Treatment begins only after medical evaluation and risk screening.
Reliable sourcing Prescriptions are filled through licensed U.S. pharmacies.
Ongoing monitoring Dosing, tolerance, laboratory results, and response are reviewed over time.

Important: Compounded medications are not generic versions of FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality before marketing. Added ingredients such as vitamin B12 should not be presented as proven to improve semaglutide’s effectiveness or tolerability.

Personalized Medical Evaluation

Who May Be a Candidate for Semaglutide?

Eligibility depends on your health history, treatment goals, metabolic profile, and a licensed provider’s clinical evaluation.

Weight-management criteria

Semaglutide May Be Considered for Adults Who:

  • Have a BMI of 30 or higher
  • Have a BMI of 27 or higher with a weight-related condition, such as hypertension, type 2 diabetes, or high cholesterol
  • Want medically supervised, long-term weight management
  • Are prepared to combine treatment with nutrition, physical activity, and ongoing follow-up
Before treatment

Safety Screening

  • Medical and medication history
  • Metabolic health and relevant laboratory results
  • Pregnancy or pregnancy plans
  • Gastrointestinal and kidney health
  • Pancreatitis or gallbladder history

Semaglutide is contraindicated for patients with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, or a serious allergy to semaglutide or its ingredients.

Is Semaglutide Right for You?

A personalized consultation can help determine whether semaglutide—or another treatment approach—best fits your health needs and long-term goals.

Book Your Consultation

Prescription treatment requires medical evaluation. Eligibility, dosing, monitoring, and individual results vary.

Compliance and Safety

Semaglutide should be prescribed for an appropriate indication following medical evaluation and ongoing clinical monitoring.

Medical supervision

Responsible Prescribing

  • Comprehensive medical evaluation
  • Eligibility and risk screening
  • Individualized dosing
  • Ongoing monitoring and follow-up
Reliable sourcing

Licensed U.S. Pharmacies

Prescribed medications are sourced through appropriately licensed pharmacies.

  • Verified medication source
  • Clear storage instructions
  • Product-specific dosing guidance
Sources to avoid

Unverified GLP-1 Products

  • Overseas or gray-market vendors
  • Unregulated online sellers
  • Counterfeit formulations
  • Unauthorized semaglutide salt forms
Patient safety, medication quality, and sustainable long-term care remain our priorities.

Frequently Asked Questions

Yes. Semaglutide is FDA-approved for:

  • Type 2 diabetes (Ozempic® and Rybelsus®)
  • Chronic weight management (Wegovy®)

Use outside approved indications is considered off-label and requires provider evaluation.

Treatment duration varies based on:

  • Goals
  • Metabolic health
  • Weight-loss response
  • Long-term maintenance plans

Some patients use semaglutide short-term, while others remain on therapy longer-term under physician supervision.

Some weight regain is common after discontinuation, particularly if long-term nutrition, exercise, and metabolic habits have not been fully established.

This is why our programs emphasize:

  • Sustainable lifestyle changes
  • Hormonal optimization
  • Muscle preservation
  • Body composition tracking
  • Long-term metabolic health

The most common side effects include:

  • Nausea
  • Constipation
  • Diarrhea
  • Reflux or stomach discomfort
  • Early fullness
  • Fatigue

These effects are most common during dose escalation and often improve with time.

Less common but more serious risks may include:

  • Pancreatitis
  • Gallbladder disease
  • Severe dehydration
  • Thyroid-related concerns

Proper medical screening and monitoring are essential.

Rapid weight loss can sometimes contribute to lean muscle loss if:

  • Protein intake is inadequate
  • Resistance training is absent
  • Hormonal imbalances are unaddressed

At Alpha Hormones®, our goal is body composition optimization—not simply lowering body weight.

Depending on the individual, treatment may also involve:

  • TRT or hormone optimization
  • Peptide therapy
  • Resistance training guidance
  • Nutritional support
  • Metabolic optimization strategies

In many cases, yes.

Hormones and metabolism are deeply interconnected. Low testosterone, thyroid dysfunction, estrogen decline, poor sleep, and metabolic dysfunction can all impact weight regulation and treatment response.

Depending on the patient, semaglutide may be coordinated alongside:

  • TRT
  • BHRT
  • Thyroid optimization
  • NAD+ therapy
  • Peptide therapy

Coverage varies depending on:

  • Insurance carrier
  • Diagnosis
  • Employer exclusions
  • Prior authorization requirements

Some plans may cover semaglutide for diabetes while excluding weight-management indications.

Our team can assist with:

  • Insurance verification
  • Prior authorization review
  • Pharmacy option discussions

In many cases, yes. HSA and FSA cards are commonly accepted for:

  • Consultations
  • Labs
  • Prescribed medications
  • Medical weight management services

Eligibility depends on your individual plan administrator.

Unregulated semaglutide products have been associated with:

  • Incorrect dosing
  • Contamination
  • Unauthorized salt forms
  • Counterfeit products

At Alpha Hormones®, we only prescribe through licensed U.S. pharmacies and regulated supply chains.

Semaglutide primarily targets GLP-1 receptors.

Tirzepatide targets:

  • GLP-1 receptors
  • GIP receptors

Retatrutide is an investigational triple agonist currently under study.

A consultation helps determine which therapy, if any, may best align with your goals and metabolic profile.

Schedule Your Semaglutide Consultation in Pasadena

If you’re considering semaglutide, begin with a comprehensive medical consultation—not a rushed prescription.

At Alpha Hormones® in Pasadena, our providers assess your hormones, metabolic health, body composition, lifestyle, and long-term goals to determine whether semaglutide—or another treatment—may be appropriate for you.

Ready to explore your options?

Disclaimer

Semaglutide is FDA-approved for specific medical indications and is prescribed only after evaluation by a licensed medical provider. This content is educational only and does not replace personalized medical advice. Individual results vary and are never guaranteed. All therapies should be reviewed with a qualified healthcare provider before starting, adjusting, or stopping treatment.